Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $3.79 -2.07%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $5.00 (from $7.00) while maintaining a Outperform rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- CLSA Downgrades Jiangsu Yanghe Brewery (002304:CH) to Hold (3)
- Dycom Industries (DY) PT Lowered to $375 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
